Compound Detail
CHEMBL3344081
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C
Basic Information
| ChEMBL ID | CHEMBL3344081 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | GFVIEZBZIUKYOG-SVFBPWRDSA-N |
4
Targets
24
Activities
2
Assay Types
4
PK Parameters
20
Publications
0
Known Names
Molecular Properties
472.6
MW (Da)
2.25
ALogP
6
HBA
3
HBD
111.6
PSA (Ų)
0.60
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 12 meas. best 6.73
Kd 12 meas. best 6.97
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Von Hippel-Lindau disease tumor suppressor/Elongin B/Elongin C CHEMBL3301400 | Kd | 6.97 | 6.8575 | 107.0 | 4 |
| von Hippel-Lindau disease tumor suppressor CHEMBL3108660 | Kd | 6.95 | 6.78 | 113.0 | 8 |
| von Hippel-Lindau disease tumor suppressor CHEMBL3108660 | IC50 | 6.73 | 6.1583 | 185.0 | 6 |
| Unchecked CHEMBL612545 | IC50 | 6.69 | 6.122 | 204.0 | 5 |
| von Hippel-Lindau disease tumor suppressor/Elongin-C/Elongin-B/HIF1A CHEMBL4296117 | IC50 | 6.1 | 6.1 | 800.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 0.7 | mL.min-1.g-1 | Mus musculus |
| T1/2 | 0.002093 | hr | Homo sapiens |
| T1/2 | 3.0 | hr | Not specified |
| T1/2 | 0.0008278 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 28853884 | 10.1021/acs.jmedchem.7b00675 | Von Hippel-Lindau disease tumor suppressor/Elongin B/Elongin C | 11 |
| 28692295 | 10.1021/acs.jmedchem.7b00635 | von Hippel-Lindau disease tumor suppressor/Serine/threonine-protein kinase TBK1 | 2 |
| 28853884 | 10.1021/acs.jmedchem.7b00675 | No relevant target | 2 |
| 28853884 | 10.1021/acs.jmedchem.7b00675 | ADMET | 2 |
| 38809766 | 10.1021/acs.jmedchem.3c02203 | von Hippel-Lindau disease tumor suppressor | 2 |
| 34638033 | 10.1016/j.ejmech.2021.113871 | Unchecked | 2 |
| 34638033 | 10.1016/j.ejmech.2021.113871 | No relevant target | 2 |
| 38478885 | 10.1021/acs.jmedchem.3c02123 | von Hippel-Lindau disease tumor suppressor | 1 |
| 25166285 | 10.1021/jm5011258 | von Hippel-Lindau disease tumor suppressor | 1 |
| 38621319 | 10.1016/j.bmc.2024.117718 | von Hippel-Lindau disease tumor suppressor | 1 |
| 37224698 | 10.1016/j.bmc.2023.117334 | von Hippel-Lindau disease tumor suppressor | 1 |
| 30629437 | 10.1021/acs.jmedchem.8b01631 | von Hippel-Lindau disease tumor suppressor | 1 |
| 36242985 | 10.1016/j.ejmech.2022.114821 | von Hippel-Lindau disease tumor suppressor/Vascular endothelial growth factor receptor 2 | 1 |
| 36206538 | 10.1021/acs.jmedchem.2c01491 | von Hippel-Lindau disease tumor suppressor | 1 |
| 34638033 | 10.1016/j.ejmech.2021.113871 | Hypoxia-inducible factor 1-alpha | 1 |
| 34638033 | 10.1016/j.ejmech.2021.113871 | HeLa | 1 |
| 34881891 | 10.1021/acs.jmedchem.1c01496 | von Hippel-Lindau disease tumor suppressor | 1 |
| 32142281 | 10.1021/acs.jmedchem.9b01451 | von Hippel-Lindau disease tumor suppressor | 1 |
| 30990042 | 10.1021/acs.jmedchem.8b01572 | Unchecked | 1 |
| 28692295 | 10.1021/acs.jmedchem.7b00635 | von Hippel-Lindau disease tumor suppressor/Elongin-C/Elongin-B/HIF1A | 1 |
Data from ChEMBL 36 via Core Engine